Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation
Cancer Medicine · 2025
DOI: 10.1002/cam4.70737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Shi Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Bone Neoplasms, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
The increasing incidence of gastric cancer (GC) in younger populations, coupled with population aging, has highlighted distinct age‐related subtypes with unique clinical characteristics and outcomes. Although younger patients tend to have more aggressive tumors, the prognostic factors for early‐onset gastric cancer (EOGC) remain underexplored. This study is dedicated to providing a comprehensive and in‐depth analysis of prognostic factors in EOGC, aiming to refine personalized treatment strategies under the precision medicine paradigm.
Methods
This retrospective study encompassed 413 local cohort EOGC patients and 8447 Surveillance, Epidemiology, and End Results database patients diagnosed with GC. Survival outcomes were assessed using Kaplan–Meier survival curves, and differences between groups were evaluated with the log‐rank test. Prognostic factors were identified through logistic regression and Cox proportional hazards models. Mediation analysis was conducted to assess the indirect effects of clinical factors on EOGC and prognosis. Biomarker comparisons between bone metastasis early‐onset gastric cancer and non‐bone metastasis early‐onset gastric cancer groups were evaluated using the Wilcoxon test for significant differences.
Results
The overall survival and cancer‐specific survival rates in the EOGC group were significantly lower than those in the non‐early‐onset gastric cancer group ( p < 0.05). However, EOGC itself was not an independent risk factor for poor prognosis. Mediation analysis revealed that the adverse impact of EOGC on prognosis was predominantly mediated by metastasis, with bone metastasis identified as the most significant factor. Furthermore, bone metastasis emerged as an independent predictor of poor prognosis in EOGC patients, potentially linked to elevated coagulation markers, increased inflammation‐related cytokines, and an imbalance in peripheral blood immune cell ratios.
Conclusions
Bone metastasis significantly contributes to the poor prognosis of EOGC. EOGC patients with bone metastasis demonstrate immune suppression, inflammation activation, and coagulopathy, highlighting the need for tailored management and prognostic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Medical Oncology, The Sixth Affiliated Hospital of Sun-Yat sen University, Guangzhou, People's Republic of China.
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
- State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.
- Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
ORCID-Profile: Shi Yin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Yin, S., Zhai, X., Li, Y., Zeng, R., Zhang, D., Sun, X., Zhang, Z., Wang, H., & Wang, C. (2025). Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation. Cancer Medicine. https://doi.org/10.1002/cam4.70737
Vancouver
Yin S, Zhai X, Li Y, Zeng R, Zhang D, Sun X, et al. Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation. Cancer Medicine. 2025. doi:10.1002/cam4.70737
BibTeX
@article{Yin2025,
author = {Yin, Shi and Zhai, Xiaohui and Li, Yaoying and Zeng, Ruixin and Zhang, Di and Sun, Xiaoqing and Zhang, Ziying and Wang, Huashe and Wang, Caiqin},
title = {Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70737}
}
EUVIMED